A precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. Our vision is to elevate precision medicine to the forefront of every cancer treatment journey, as we believe that each patient living with cancer deserves the opportunity to benefit from a genomically-driven treatment decision.
Lead Underwriter
Cowen and Company, LLC, J.P. Morgan Securities LLC, SVB Leerink LLC
